Skip to main navigation Skip to search Skip to main content

Anesthetic considerations in psychiatric disease

  • Harvard Medical School
  • Brigham and Women's Hospital

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

Abstract

Lifetime prevalence of significant depressive symptoms is 13% to 20% and 3.7% to 6.7% for major depressive disorder. Depressive patients experience a wide range of clinical symptoms ranging from lack of pleasure and sleeping problems to psychomotor retardation or even committing suicide in extreme cases.

Original languageEnglish
Title of host publicationEssential Clinical Anesthesia Review
Subtitle of host publicationKeywords, Questions and Answers for the Boards
PublisherCambridge University Press
Pages51-55
Number of pages5
ISBN (Electronic)9781139584005
ISBN (Print)9781107681309
DOIs
Publication statusPublished - 1 Jan 2015
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Bipolar disorder: Lithium Lithium toxicity Anesthetic Considerations
  • Depression: Antidepressants (tricyclic antidepressants SSRIs SNRIs MAOIs) Anesthetic implications Serotonin syndrome Serotonin syndrome
  • Schizophrenia: Antipsychotics (typical Atypical) Anesthetic considerations Neuroleptic malignant Syndrome

Fingerprint

Dive into the research topics of 'Anesthetic considerations in psychiatric disease'. Together they form a unique fingerprint.

Cite this